AHCYL1 Is a Novel Biomarker for Predicting Prognosis and Immunotherapy Response in Colorectal Cancer

CONCLUSION: For CRC patients, the prognostic model based on AHCYL1 and AHCYL1-related genes showed a high predictive performance in terms of prognosis and immunotherapy response.PMID:35578598 | PMC:PMC9107370 | DOI:10.1155/2022/5054324

Source: Journal of Oncology - May 17, 2022 Category: Cancer & Oncology Authors: Xubin Li Mengqiao Zhang Xue Yu Mei Xue Xiaowei Li Chao Ma Wei Jia Qiang Gao Chunbo Kang Source Type: research